Walter N Kernan Selected Research

Pioglitazone (Actos)

1/2022	Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
10/2020	Adherence to study drug in a stroke prevention trial"?>.
1/2019	Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
12/2018	Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk.
1/2018	Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial.
1/2018	Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
1/2018	Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
11/2017	Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.
10/2017	Smoking cessation and outcome after ischemic stroke or TIA.
10/2017	Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter N Kernan Research Topics

Disease

32	Stroke (Strokes) 01/2022 - 04/2003
20	Insulin Resistance 01/2022 - 06/2003
20	Ischemic Stroke 10/2020 - 06/2003
17	Transient Ischemic Attack 10/2020 - 06/2003
12	Myocardial Infarction 01/2022 - 07/2005
7	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 01/2005
6	Diabetes Mellitus 12/2018 - 11/2004
5	Heart Failure 01/2022 - 01/2018
4	Bone Fractures (Bone Fracture) 01/2022 - 04/2016
4	Hypertension (High Blood Pressure) 01/2018 - 06/2003
3	Weight Gain 01/2022 - 04/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 05/2017
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2005
2	Acute Coronary Syndrome 01/2019 - 05/2017
2	Prediabetic State (Prediabetes) 01/2019 - 11/2004
2	Chronic Renal Insufficiency 12/2018 - 12/2018
2	Edema (Dropsy) 01/2018 - 04/2016
2	Obesity 01/2018 - 06/2003
2	Cognitive Dysfunction 02/2005 - 04/2003
2	Glucose Intolerance 01/2005 - 11/2004
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Atrial Fibrillation 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Unstable Angina 05/2017
1	Abdominal Obesity 07/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2014
1	Blood Vessel Dissection 01/2011
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2011
1	Cerebral Hemorrhage 01/2011
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2011
1	Hyperhomocysteinemia 01/2011
1	Patent Foramen Ovale 01/2011
1	Brain Diseases (Brain Disorder) 01/2005
1	Hemorrhagic Stroke 06/2003

Drug/Important Bio-Agent (IBA)

19	Pioglitazone (Actos)FDA Link 01/2022 - 06/2003
11	Insulin (Novolin)FDA Link 01/2019 - 06/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2003
6	Pharmaceutical PreparationsIBA 01/2022 - 06/2003
4	Estrogens (Estrogen)FDA Link 11/2005 - 04/2003
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2018 - 12/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2018 - 12/2018
2	C-Reactive ProteinIBA 01/2018 - 07/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 11/2004
2	Caffeine (No Doz)FDA LinkGeneric 09/2005 - 06/2003
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Sodium-Glucose Transport ProteinsIBA 12/2018
1	SodiumIBA 12/2018
1	SmokeIBA 10/2017
1	HDL LipoproteinsIBA 07/2016
1	Triglycerides (Triacylglycerol)IBA 07/2016
1	Therapeutic UsesIBA 01/2015
1	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 07/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2014
1	Hormones (Hormone)IBA 01/2011
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2011
1	CholesterolIBA 10/2010
1	HDL CholesterolIBA 07/2005
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2005
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2005
1	candesartan cilexetil (Amias)FDA Link 12/2003
1	Nicotine FDA Link 06/2003
1	Blood Glucose (Blood Sugar)IBA 06/2003
1	Cocaine (Cocaine HCl)IBA 06/2003

Therapy/Procedure

12	Therapeutics 01/2019 - 12/2003
8	Secondary Prevention 01/2022 - 06/2012
3	Glycemic Control 06/2012 - 11/2004
1	Drug Tapering 01/2018
1	Diet Therapy (Therapy, Diet) 01/2015
1	Hysterectomy 04/2003